Creo Medical Group (CREO)

Sector:

Health Care

Index:

FTSE AIM All-Share

12.88p
   
  • Change Today:
    -0.13p
  • 52 Week High: 39.50
  • 52 Week Low: 12.25
  • Currency: UK Pounds
  • Shares Issued: 412.47m
  • Volume: 423,268
  • Market Cap: £53.11m

CREO Overview

Creo Medical was founded in 2003 as MicroOncology Ltd by Professor Chris Hancock, initially to target the treatment of cancers through use of high frequency microwave energy and dynamic matching techniques.

Key Personnel

CEO: Craig Jonathan Gulliford
CFO: Richard John Rees
Chief Technology Officer: Christopher Paul Hancock
Executive Director: David Gerard Woods
Independent Non-Executive Director: Ivonne Cantu
Independent Non-Executive Director: Kevin Crofton
Independent Non-Executive Director: John Bradshaw
Independent Non-Executive Director: Brent Boucher
Non-Executive Chairman: Charles Spicer
Non-Executive Dir:

Contact Details

Address: Creo House, Unit 2 Beaufort Park, Beaufort Park Way, Chepstow, Wales, United Kingdom , NP16 5UH
Phone: +44 (0) 1291 606005
Website: http://creomedical.com/

Listings

Sector: Health Care(LSE)
Index: FTSE AIM All-Share
ISIN: GB00BZ1BLL44

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

CREO Market Data

Currency UK Pounds
Share Price 12.88p
Change Today -0.13p
% Change -0.96 %
52 Week High 39.50
52 Week Low 12.25
Volume 423,268
Shares Issued 412.47m
Market Cap £53.11m

CREO Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
25.50% above the market average25.50% above the market average25.50% above the market average25.50% above the market average25.50% above the market average
9.09% below the sector average9.09% below the sector average9.09% below the sector average9.09% below the sector average9.09% below the sector average
Price Trend
81.03% below the market average81.03% below the market average81.03% below the market average81.03% below the market average81.03% below the market average
62.16% below the sector average62.16% below the sector average62.16% below the sector average62.16% below the sector average62.16% below the sector average
Income Not Available
Growth
26.56% above the market average26.56% above the market average26.56% above the market average26.56% above the market average26.56% above the market average
41.18% above the sector average41.18% above the sector average41.18% above the sector average41.18% above the sector average41.18% above the sector average

What The Brokers Say

Strong Buy 1
Buy 0
Neutral 0
Sell 0
Strong Sell 0
Total 1
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

CREO Dividends

No dividends found

Trades for 01-Apr-2025

Time Volume / Share Price
16:03 2,756 @ 12.94p
15:49 10,784 @ 12.82p
15:19 8,000 @ 12.82p
13:54 17,976 @ 12.82p
13:36 4,000 @ 12.95p

CREO Key Personnel

CEO Craig Jonathan Gulliford
CFO Richard John Rees

Top of Page